Showing results (1291-1300 of 1,428) with videos related to
Sort By:
Pageof 143
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 20, 2016
[Discovery of a novel spliceosome of ABL gene (ABL(Δexon7+35INS)) and its association with TKIs resistance in chronic myeloid leukemia]J Pan, Y H Tan, J X Zhao, et al.Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|October 9, 2018
[Analysis of the arthropathies on no-bleeding history joints in pre-school age severe hemophilia A children]D Ai, X J Li, W R Yao, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|February 18, 2020
[Prevalence and risk factors of diabetic peripheral neuropathy in Chinese communities]L Qin, J Y Niu, J Y Zhou, et al.Allergy|June 23, 2015
Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polypsB Liao, P-P Cao, M Zeng, et al.Immunology|January 13, 2012
Increased survival and reduced renal injury in MRL/lpr mice treated with a human Fcγ receptor II (CD32) peptideJun Xi, Gai P Zhang, Song L Qiao, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 26, 2022
[The prevalence and risk factors of diabetic peripheral artery disease in Chinese communities]L Qin, B Chen, J Y Niu, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 2, 2021
Enhanced high temperature ferromagnetism in Bi1-RFeO3(R= Dy, Y) compoundsN Zhang, J Q Ding, Y P Wang, et al.Genetics and Molecular Research : GMR|November 5, 2015
Association between IL2/IL21 and SH2B3 polymorphisms and risk of celiac disease: a meta-analysisC C Guo, W H Huang, N Zhang, et al.Rhinology|August 18, 2025
ITGAM and FCGR3B contribute to recurrent and limited CRSwNP in children through phagosome pathwayX Xiao, X Chen, W Liu, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trialC Zhao, J Miao, G Shen, et al.Pageof 143